68
Allgens Medical Technology Co. Ltd.
688613.SS · SHH
¥20.15 -1.71% (-¥0.35)
1M +28.03%
Market Cap ¥2.76B
P/E Ratio 348.14x
Div. Yield 0.15%
ROE 0.55%
Bulios Fair Price
¥14.06
30.2% downside
Current Price
¥20.15
Undervalued Fair Value Overvalued
According to Bulios Fair Price, 688613.SS is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
6/9Valuation
14 /100
Expensive P/S 12.13x
P/E 348.14x
P/B 1.92x
Growth
6 /100
Declining FCF growth 42.86%
EPS growth 47.97%
Book val. growth 3.26%
Profitability
30 /100
Weak Op. margin 3.61%
Gross margin 68.71%
FCF margin 14.81%
Quality
4 /100
Poor ROA 0.52%
ROIC 0.50%
Asset turnover 0.15x
Debt
86 /100
Low Int. coverage 2.27x
Debt/Equity 0.02x
Net debt/EBITDA -4.06x
Stability
56 /100
Moderate EPS volatility 173.91%
Beta 0.59x
Profitable years 1
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about 688613.SS
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Zhiye Qiu
Employees
281
Headquarters
Beijing
Upcoming events
31 OCT
Earnings
Upcoming earnings report